QHM-2025-9468 A86023 Benfield Park Medical Group Enhanced Services Contract

The procurement process managed by NHS North East and North Cumbria Integrated Care Board involves the award of the QHM-2025-9468 A86023 Benfield Park Medical Group Enhanced Services Contract under the Direct Award Process A, as outlined in the Health Care Services (Provider Selection Regime) regulations 2023. This contract, focusing on health services such as Androgen Deprivation Injections and Diabetes Care, is set to commence on 1st April 2025 and conclude on 31st March 2026. The procurement is classified under services and uses a limited procurement method, specifically an award procedure without prior publication of a call for competition.

The location for service delivery is the UKC region, and the process is currently in the award stage, having been signed on 1st October 2025. This tender provides significant opportunities for businesses within the healthcare industry, particularly those specialised in delivering enhanced health services. Given the limited procurement method, it is particularly suited for businesses with established relationships and expertise in the specific services required, such as healthcare providers offering Androgen Deprivation Injections and PSA Monitoring services.

The contract, however, presents no significant financial incentive as the stated contract value is nominal (£0.01), focusing instead on activity-based services without a guaranteed financial ceiling. Nevertheless, becoming involved in such a contract with a significant authority like the NHS can enhance a supplier's credibility and open pathways for future contracts due to the prestige associated with successful delivery in high-demand health sectors.